-74.1%
DRUG vs SPY
+1.5%
-75.6%
-78.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | SPY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +11.1% | +0.3% | +10.8% | +11.0% |
| 7D | -58.2% | -2.7% | -55.5% | -58.0% |
| 30D | -55.8% | -5.4% | -50.4% | -54.1% |
| 3M | -71.5% | -4.1% | -67.4% | -71.1% |
| 6M | -74.1% | +0.7% | -74.8% | -75.4% |
| All | -74.1% | +1.5% | -75.6% | -75.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SPY.
Daily Out/Under-Performance
Portfolio return minus SPY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded SPY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling